TriSalus Life Sciences, Inc. (TLSI) insider buying and selling

NASDAQ: TLSI · Source: SEC Form 4 filings · Latest trade reported

There were no open-market insider purchases or sales at TriSalus Life Sciences, Inc. (TLSI) in the last 90 days. Over the last 12 months, 5 insiders bought $1.8M of the stock, led by Michael P Stansky (Director), who bought $1.5M on May 15, 2026; 1 insider sold $1K, of which $1K was scheduled or tax-related.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
0
$0 · 0 insiders
Insider buys, 12 months
6
$1.8M · 5 insiders
Insider sales, 12 months
1
$1K · 1 insider

This is the public summary. Create a free account to see TLSI’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock TLSI

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at TriSalus Life Sciences, Inc.
DateInsiderTypeSharesPriceValue
Michael P Stansky
Director
Open market purchase
2 trades
610,000avg. $2.50$1.5M
Mats Wahlstrom
Director
Open market purchase60,000$2.53$152K
Mary T Szela
CEO
Open market purchase39,682$2.59$103K
Gary B. Gordon
Director
Open market purchase10,000$2.46$25K
David Patience
CFO
Open market purchase7,100$2.43$17K

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at TriSalus Life Sciences, Inc.
DateInsiderTypeSharesPriceValue
Richard Marshak
Chief Commercial Officer
Sell to cover543$2.67$1K

What the TLSI insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for TriSalus Life Sciences, Inc. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with TLSI Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about TLSI insider trading

Who bought TriSalus Life Sciences, Inc. (TLSI) stock recently?

Insiders who bought TriSalus Life Sciences, Inc. stock on the open market in the last 12 months: Michael P Stansky ($1.5M), Mats Wahlstrom ($152K), Mary T Szela ($103K), Gary B. Gordon ($25K). The most recent purchase was reported on May 15, 2026.

Are insiders buying or selling TLSI?

Over the last 12 months insiders were net buyers of TLSI on discretionary trades: $1.8M bought against $0 sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see TLSI in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.